PDRN spent decades in a very different kind of skincare context. In Italian hospitals, it was a pharmaceutical treatment for diabetic foot ulcers and skin ulcers — approved by AIFA, Italy's national medicines agency, under the brand name Placentex®. In South Korea, it was classified by the MFDS as a pharmaceutical and administered by injection as Rejuran Healer, a treatment that made PDRN synonymous with Korean aesthetic medicine. A 2024 survey of 235 Korean board-certified dermatologists found that 88% use polydeoxyribonucleotide injections in their clinical practice.
Then it showed up as "Sodium DNA" on the ingredient list of a K-beauty sheet mask.
That trajectory — from wound-care pharmaceutical to clinic treatment to K-beauty counter — is the story of how an ingredient earns its skincare credentials, and why understanding it helps you evaluate what you're actually buying. This guide covers the science, the evidence, the terminology, and the realistic expectations for PDRN in topical skincare.
What Is PDRN?
PDRN stands for polydeoxyribonucleotide — a chain of deoxyribonucleotide fragments extracted from the sperm cells of salmon (Oncorhynchus mykiss) or trout. The extraction process isolates these DNA fragments at a controlled molecular weight (roughly 50–1,500 kDa depending on preparation), strips cellular proteins to eliminate immune reactivity, and produces a purified compound with established pharmacological properties.
The name sounds more dramatic than the reality: PDRN is DNA-derived, but it doesn't interact with your own genetic material. It works through two distinct and well-characterized mechanisms:
Mechanism 1: Adenosine A2A receptor agonism PDRN selectively activates the adenosine A2A receptor (A2AR) — one of four adenosine receptor subtypes found in human tissue. When A2AR is activated, it raises intracellular cAMP levels and triggers downstream signaling that suppresses inflammatory cytokine production (via NF-κB and MAPK pathways), while simultaneously promoting cell proliferation, VEGF (vascular endothelial growth factor) production, and collagen synthesis in dermal fibroblasts.
Mechanism 2: Nucleotide salvage Stressed, hypoxic, or damaged tissue often cannot perform efficient de novo DNA synthesis. PDRN donates deoxyribonucleotide building blocks that cells can internalize and use for repair — a molecular shortcut that helps compromised cells recover and replicate.
These two mechanisms operate independently but toward compatible outcomes: reduced inflammation, accelerated cellular repair, and increased structural protein production.
A Clarification: PDRN, PN, and Sodium DNA
Before going further, it's worth untangling a terminology issue that affects most of the PDRN content you'll encounter online — and on ingredient labels.
PDRN and PN (polynucleotide) are related but not the same. PDRN consists of shorter DNA fragments (lower molecular weight), works primarily via the A2A receptor and nucleotide salvage, and is classified as a pharmaceutical in South Korea. PN consists of longer DNA chains (higher molecular weight), forms a more viscous structure, and is classified as a medical device in South Korea. A 2025 review in Pharmaceutics provides the clearest comparative breakdown of their distinct molecular profiles and clinical applications.
Here is the part that trips up most consumers: the most famous "PDRN injection," Rejuran Healer, actually contains PN — not PDRN. This is regularly glossed over in both marketing and editorial content.
Sodium DNA is the INCI (International Nomenclature of Cosmetic Ingredients) name used for both PDRN and PN in cosmetic formulations. The INCI does not distinguish between fragment lengths or molecular weights — meaning that when you see "Sodium DNA" on a label, you cannot determine from the label alone whether the product contains pharmaceutical-grade PDRN, PN, a lower-grade hydrolyzed DNA fragment, or a plant-derived DNA alternative.
This is standard across cosmetic ingredient nomenclature. But it's worth knowing before taking brand claims about "PDRN content" at face value.
4 Science-Backed Mechanisms
1. Wound Healing and Tissue Regeneration
The clinical evidence for PDRN's biological activity is strongest in wound healing and tissue regeneration — which is where it spent decades as a pharmaceutical before cosmetics caught on.
A comprehensive 2017 review in Frontiers in Pharmacology documented PDRN's pharmaceutical track record across wound healing, joint disease, hair loss, and ischemia. In a randomized controlled trial of diabetic foot ulcers, 37.3% of patients treated with PDRN achieved complete wound healing versus 18.9% in the placebo group after 8 weeks. Post-marketing surveillance of more than 300,000 PDRN prescriptions recorded no toxic effects.
A 2021 review in Pharmaceuticals covering more than 30 studies confirmed these findings — PDRN consistently doubled healing rates versus placebo in diabetic wound models, with excellent tolerability in both animal and human trials. A 2020 systematic review in Regenerative Medicine examined 34 qualifying studies and concluded that PDRN shows "promising results in wound regeneration, healing time, and absence of side effects."
For skincare, the relevance is the cellular repair mechanism itself: the A2A receptor agonism and nucleotide salvage pathways that drive wound healing are the same pathways active in post-blemish skin recovery, post-procedure repair, and stressed or sensitized skin.
2. Anti-Inflammatory Action
PDRN's activation of the adenosine A2A receptor directly suppresses the NF-κB and MAPK inflammatory signaling cascades — the same pathways implicated in post-breakout redness, environmental skin stress, and chronic low-grade inflammation that contributes to premature aging.
In practical skincare terms, this makes PDRN an anti-inflammatory ingredient with a specific receptor-level mechanism — not a vague "calming" claim, but a documented molecular pathway. The inflammatory suppression works alongside the cellular repair mechanism, making PDRN particularly relevant for skin that needs both calming and recovery at the same time.
3. Collagen Support and Skin Structure
PDRN's A2A receptor activation promotes VEGF production in tissue and upregulates collagen type I and III synthesis in dermal fibroblasts, while simultaneously downregulating MMP-1 (matrix metalloproteinase-1) — the enzyme responsible for collagen degradation.
The dual action — building new collagen while slowing its breakdown — places PDRN in the same mechanistic category as adenosine and some peptides, though via a different signaling pathway. In the 2024 Korean clinical survey, patients receiving intradermal PN injections showed measurable improvements in skin thickness, wrinkle appearance, pore size, and firmness alongside tone improvements.
4. Brightening and Anti-Melanogenic Effects
This is the mechanism most relevant to K-beauty's core concerns — and the one most consistently missing from consumer content.
A 2016 study in the International Journal of Molecular Sciences documented that PDRN significantly reduced melanin content, tyrosinase activity, and expression of MITF and TRP-1 — key regulators of melanin synthesis — in both mouse and human melanocyte cultures. The mechanism operates via ERK and AKT phosphorylation pathways. A small clinical pilot (six patients with facial hyperpigmentation, three intradermal sessions) showed visible improvement across all six subjects.
Tyrosinase inhibition is the mechanism shared with ingredients like niacinamide and kojic acid — but through a distinct pathway. For an audience focused on post-blemish dark marks and uneven tone, this is PDRN's most directly applicable skincare benefit. It appears in the peer-reviewed literature; it's simply been largely overlooked in consumer coverage.
The Topical Question
Here is where honesty matters more than trend enthusiasm.
The research above is largely from injectable and wound-care contexts. Topical delivery of PDRN faces a meaningful challenge: molecular weight. At 50–1,500 kDa, PDRN molecules are substantially larger than the accepted passive cutaneous penetration threshold of approximately 500 Da for intact skin. Molecules this size do not cross the stratum corneum in clinically significant quantities without technological assistance.
This does not mean topical PDRN products are ineffective — it means that delivery technology determines how much of the established benefit is accessible. A 2025 study in Pharmaceutics demonstrated that nitrogen-oxygen plasma treatment reduced PDRN particle size from approximately 300 nm to approximately 10 nm, achieving 10.7 times greater transdermal flux compared to untreated PDRN — with measurable improvements in skin texture and radiance in human subjects.
Nanosizing, liposomal encapsulation, and capsule-burst delivery systems are all legitimate approaches to the same problem. When evaluating a PDRN topical product, delivery technology matters alongside the presence of Sodium DNA on the label. Brands that address this specifically are solving the right problem; those that simply import injectable study data to support topical claims are skipping a step.
Vegan PDRN: Plant-Derived Alternatives
Salmon-derived PDRN is the established standard, but plant-derived alternatives are an emerging category.
A 2023 study in Molecules examined PDRN extracted from Panax ginseng (C.A. Mey.) adventitious roots — a fully vegan source. Researchers confirmed A2A receptor activation and promotion of wound healing and skin barrier strengthening in a 3D artificial skin model: the first significant scientific validation of plant-sourced PDRN.
The honest assessment: plant-derived PDRN has preliminary biological support and is a credible option for vegan consumers. The evidence base is smaller than for salmon PDRN, and direct comparative clinical trials have not been published. That gap may close as the category grows.
Who Is PDRN Best Suited For?
PDRN's established mechanisms — anti-inflammatory, cellular repair support, anti-melanogenic, collagen stimulation — point to specific skincare applications:
- Post-blemish skin: Anti-inflammatory and tyrosinase-inhibiting mechanisms address both redness and dark marks after breakouts have cleared
- Sensitized or barrier-disrupted skin: The nucleotide salvage pathway supports cellular recovery from irritation and stress
- Aging or fatigued skin: Collagen and VEGF stimulation mechanisms are well-established; topical delivery technology determines accessibility
- Uneven skin tone and hyperpigmentation: The anti-melanogenic mechanism (Noh et al. 2016) makes PDRN relevant for brightening concerns beyond post-blemish use
- Post-procedure skin: PDRN's pharmaceutical wound-healing origins make it a logical fit for recovery from chemical peels, laser treatments, and other procedures
PDRN has an exceptional safety record — 300,000+ pharmaceutical prescriptions with no toxic effects documented. It is non-irritating, non-comedogenic, and carries no photosensitivity risk, making it suitable for morning and evening use. Those with fish or seafood allergies should patch test as a standard precaution, though no clinical cross-reactivity cases have been confirmed in published literature.
What to Look for in a Product
If you're evaluating PDRN skincare products, three factors matter beyond the ingredient name:
- Delivery system: Look for nanosized, liposomal, encapsulated, or capsule-burst formats. These address the molecular weight penetration challenge.
- INCI placement: "Sodium DNA" appearing in the first half of an ingredient list (before preservatives) suggests a meaningful concentration. Deep in the list is likely decorative.
- Sourcing transparency: Salmon-derived vs. plant-derived vs. hydrolyzed DNA (the lowest-activity form) produce different biological profiles. Brands with nothing to hide are specific about this.
A Note on Our Products
PDRN — listed as Sodium DNA — is a key active in a new Jindelle treatment mask currently in development, focused on post-blemish recovery. It works alongside a full centella triterpenoid constellation, 2% niacinamide, and zinc PCA to address post-blemish marks, uneven tone, and barrier recovery in a single application.
Coming soon — we'll link directly to the product page once it's live.
Frequently Asked Questions
Is PDRN the same as "salmon sperm" skincare? Yes. PDRN is extracted from salmon or trout sperm cells, then purified of all proteins and cellular material — leaving only the DNA fragments. "Salmon DNA," "salmon sperm skincare," and "fish DNA skincare" all refer to the same source material.
What's the difference between PDRN and polynucleotide (PN)? PDRN consists of shorter DNA fragments and is classified as a pharmaceutical in Korea. PN consists of longer chains and is classified as a medical device. Both appear on cosmetic labels as "Sodium DNA." Rejuran Healer — the most famous K-beauty PDRN injection — actually contains PN, not PDRN.
Will a PDRN sheet mask produce the same results as a clinic injection? No — and any brand implying this should be approached carefully. Injectable PDRN delivers the compound directly to the dermis; topical PDRN faces a molecular weight barrier at the skin surface that delivery technology must address. A well-formulated topical can offer real benefit, but it is not equivalent to an intradermal injection. Honest brands acknowledge this distinction.
Is plant-derived PDRN as effective as salmon PDRN? Plant-derived PDRN (typically from ginseng) has early scientific support — a 2023 study confirmed A2A receptor activation and wound healing effects in a 3D skin model. The evidence base is smaller than for salmon-derived PDRN, and direct head-to-head comparisons have not been published. It is a credible option, not a proven equivalent.
Is PDRN safe for sensitive skin? PDRN has an exceptionally well-documented safety profile — more than 300,000 pharmaceutical prescriptions with no toxic effects reported. For topical use, it is non-irritating, non-comedogenic, and carries no photosensitivity risk. Patch testing is standard practice for new actives; those with fish or seafood allergies should apply this precaution here.
The Bottom Line
PDRN's arrival in K-beauty ingredient lists is backed by one of the stronger pharmaceutical track records available — a well-characterized dual mechanism, randomized clinical trial evidence in wound healing, documented anti-melanogenic effects, and an excellent safety record across hundreds of thousands of prescriptions.
The honest caveat is topical delivery: most PDRN molecules are too large to penetrate intact skin without technological intervention, and the injectable evidence base does not automatically transfer to a serum or sheet mask. The brands worth paying attention to are those addressing delivery technology directly, rather than borrowing clinic study citations for a product that hasn't solved the penetration problem.
For post-blemish skin, sensitized skin, or anyone interested in the leading edge of K-beauty formulation, PDRN is a credible and scientifically grounded ingredient — one whose brightening potential is, notably, the least discussed and most relevant for a K-beauty audience.
References
Footnotes
-
Rho NK, Kim HS, Kim SY, Lee W. (2024). Injectable skin boosters: An updated narrative review with a focus on polynucleotides and poly-L-lactic acid. Archives of Plastic Surgery. https://pmc.ncbi.nlm.nih.gov/articles/PMC11560330/ ↩ ↩2
-
Squadrito F, Bitto A, Irrera N, et al. (2017). Pharmacological activity and clinical use of PDRN. Frontiers in Pharmacology, 8, 224. https://pmc.ncbi.nlm.nih.gov/articles/PMC5405115/ ↩ ↩2 ↩3 ↩4 ↩5
-
Kim ST. (2025). Comparative analysis of polynucleotide and polydeoxyribonucleotide in dermatological applications. Pharmaceutics. https://pmc.ncbi.nlm.nih.gov/articles/PMC12388916/ ↩
-
Galeano M, Pallio G, Irrera N, et al. (2021). PDRN therapeutic approach: A comprehensive review. Pharmaceuticals, 14(11), 1103. https://pmc.ncbi.nlm.nih.gov/articles/PMC8618295/ ↩ ↩2
-
Colangelo MT, Galli C, Guizzardi S. (2020). Polydeoxyribonucleotide: Mechanisms of action and clinical applications — a systematic review. Regenerative Medicine, 15(7), 1801–1821. https://pubmed.ncbi.nlm.nih.gov/32757710/ ↩
-
Noh TK, Chung BY, Kim SY, et al. (2016). Novel anti-melanogenesis properties of polydeoxyribonucleotide. International Journal of Molecular Sciences, 17(9), 1448. https://pubmed.ncbi.nlm.nih.gov/27598132/ ↩
-
Park et al. (2025). Enhanced transdermal delivery of polydeoxyribonucleotide via nitrogen-oxygen plasma treatment. Pharmaceutics. https://pmc.ncbi.nlm.nih.gov/articles/PMC12473307/ ↩
-
Lee KS, Lee S, Wang H, et al. (2023). Plant-derived polydeoxyribonucleotide from Panax ginseng promotes wound healing and skin barrier strengthening. Molecules, 28(21), 7240. https://pubmed.ncbi.nlm.nih.gov/37959659/ ↩